12 Biggest Mid-Day Losers For Tuesday
September 05, 2017 at 12:53 PM EDT
Cellectis SA (ADR) (NASDAQ: CLLS) shares dipped 21.4 percent to $25.30 after announcing FDA clinical hold of UCART123 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.